MedPath

Menstrual Cycle Hormones and Eating Behavior

Completed
Conditions
Food Preference
Dietary Habits
Registration Number
NCT01407692
Lead Sponsor
USDA, Western Human Nutrition Research Center
Brief Summary

The purpose of this study is to determine if the phase of the menstrual cycle (opposed versus unopposed estrogen phase) affects eating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger.

Detailed Description

This is an observational study to investigate the effect of endogenous estrogen (E2) and progesterone (P4) levels on eating behavior and energy-yielding nutrient metabolism. Eating behavior will be assessed during a complete menstrual cycle during the first month of the study. Participants will track the follicular and luteal phases of their menstrual cycle using urinary leuteinizing hormone (LH) kits, they will record information about their food intake, eating behaviors, and appetite in their home environments, and they will complete two laboratory test days: one test day scheduled during their follicular phase, and one test day scheduled during their luteal phase.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Body Mass Index between 20-30 Kg/m2
  • regular menstrual cycles
  • sedentary lifestyle (physical activity not more than 30 minutes per day three times a week)
Exclusion Criteria
  • Fasting blood sugar greater than 110 mg/dL
  • Systolic Blood Pressure greater than 140 mmHg
  • Diastolic Blood Pressure greater than 90 mmHg
  • Fasting triglycerides greater than 120 mg/dL
  • Documented or self-reported chronic disorders such as arthritis, or other inflammatory diseases
  • Women who are Post-menopausal or Peri-menopausal
  • Pre-menopausal women who are pregnant, uni/multiparous, taking oral contraceptives, or who have menstrual cycles lasting less than 20 days or greater than 45 days, polycystic ovary syndrome (PCOS), amenorrhea, eumenorrhoea, or polymenorrhoea.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eating behaviorAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Eating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger will be measured using four questionnaires; Eating inventory: to assess dietary restraint, Stanford Brief Physical Activity Questionnaire, Food craving questionnaire, Eating behavior and attitudes questionnaire

Secondary Outcome Measures
NameTimeMethod
Insulin sensitivityAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

To determine if the phase of the menstrual cycle affects insulin sensitivity, we will measure plasma insulin, glucose and non-esterified fatty acids (NEFA).

Serum lipid profile changesAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Blood samples will be analyzed for lipids and lipoproteins, including apoproteins A1, B, C-II, C-III, and E.

EstradiolAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Estradiol measured in serum in relation to appetite variables

progesteroneAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Progesterone measured in serum in relation to appetite variables

Endocannabinoid profileAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Endocannabinoid profile measured in serum to assess appetite

Urinary c-peptideAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

The level of urinary C-peptide and creatinine will be measured in a 24-hour urine collection.

LeptinAt follicular (day 11) and luteal (day 26) phase of menstrual cycle

Leptin measured in serum to assess appetite

Dehydroepiandrosterone (DHEA)At follicular (day 11) and luteal (day 26) phase of menstrual cycle

Dehydroepiandrosterone measured in serum in relation to appetite variables

Sex Hormone Binding Globulin (SHBG)At follicular (day 11) and luteal (day 26) phase of menstrual cycle

SHBG measured in serum in relation to appetite variables

Trial Locations

Locations (1)

USDA, ARS, Western Human Nutrition Research Center

🇺🇸

Davis, California, United States

© Copyright 2025. All Rights Reserved by MedPath